US WORLDMEDS, LLC (SOLSTICE NEUROSCIENCES, LLC) Overview
Company Headquarters: Louisville, US
Founded: 2001
Workforce: ~ 51-100
Company Working:
US WorldMeds, LLC, is engaged in developing, manufacturing, and marketing a wide range of pharmaceuticals products primarily in therapeutic areas related to Parkinson’s disease, cervical dystonia, malignant hyperthermia. The company acquired Solstice Neurosciences, LLC, in the year 2010 and acquired its iconic product Myobloc. Some of the major brands of US WorldMeds, LLC, include Apokyn, Lucemyra, Corgard, Myobloc, Revonto, and Xadago. The company manufactures Myobloc which is the only botulinum toxin type B product available in the market.
Strategy
US WorldMeds, LLC concentrates on neurological, neuromuscular, and pain disorder therapeutic areas and develops innovative substitutes that are cost-effective and efficient. The company primarily focuses on the domestic market for revenue generation. Moreover, it is also engaged in increasing the product portfolio via R&D investments.
